Ramzi Khamis: Higher Levels of Natural Antibodies Against Malondialdehyde-Modified LDL
Ramzi Khamis, The Wu Family Endowed Chair of Cardiology at the National Heart and Lung Institute, posted on LinkedIn:
“Delighted to share our new publication.
This study extends the paradigm that immune responses to oxidised lipoproteins influence not only atherosclerosis, but also the biology of valvular calcification. Higher levels of natural antibodies against malondialdehyde-modified LDL (MDA-LDL), particularly IgM, were associated with less aortic and mitral valve calcification on CT imaging.
These findings lend further weight to the concept that the immune system’s recognition of oxidised lipid epitopes may confer a degree of vascular protection , an area that continues to bridge vascular immunology, lipid oxidation, and imaging science.
Congratulations to Adam Hartley and the team. We are so greatful to the outstanding SCOT-HEART team, whose meticulous imaging phenotyping and translational curiosity made this work possible. A wonderful example of how population imaging and molecular immunology can converge to illuminate new dimensions of cardiovascular disease. Kudos to Michelle Williams, David Newby and the team who made this possible.”
Title: Anti‐Malondialdehyde Low‐Density Lipoprotein Antibodies and Valvular Calcification: A Substudy of the SCOT‐HEART Trial
Authors: Adam Hartley, Michelle C. Williams, Amit Kaura, Sarah Verhemel, Mikhail Caga-Anan, Damini Dey, Marc R. Dweck, Dorian O. Haskard, Michael Joner, Manuel Mayr, David E. Newby, Ramzi Y. Khamis
Read full paper here.
Stay informed with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight